In one paragraphArticle in Metabolites, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Mengfan QiInstitute of Marine Drugs, Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Huaqing HuangInstitute of Marine Drugs, Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Lu LuInstitute of Marine Drugs, Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Zhiwei SuCollege of Agriculture, Guangxi University, Nanning 530004, China.
Xiaowei LuoInstitute of Marine Drugs, Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0002-2114-1609 Chenghai GaoInstitute of Marine Drugs, Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0002-7524-8049 Yonghong LiuInstitute of Marine Drugs, Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0001-8327-3108 Xinya XuInstitute of Marine Drugs, Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0001-5968-6869 Funding
Guangxi First-class Discipline: Chinese Materia Medica Scientific Research of Guangxi Education Department [2022] No. 1Guangxi Natural Science Foundation 2024GXNSFAA010403High-Level Talent Training Project Foundation of Guangxi University of Chinese Medicine 2022C011High-Level Talent Training Project Foundation of Guangxi University of Chinese Medicine 202407National Natural Science Foundation of China 42066006
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antifoulingbarnaclesbiofoulinglipidmarine funginatural products
Identifiers
PMID41295306
PMCPMC12654144
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390